OUR PRODUCTS

MOBILE APPS

GENERAL INFO

CELC

Stock ticker: NASDAQ

PRICE

CHANGE

CAPITALIZATION

Celcuity (CELC) Earnings Date & Reports

Celcuity Inc is a clinical-stage biotechnology company pursuing development for oncology... Show more

Industry: #Miscellaneous Commercial Services

Get AI intraday signals

A.I. Advisor

published Earnings

CELC is expected to report earnings to fall 14.97% to -88 cents per share on November 17

Q3'25

Est.

$-0.88

Q2'25

Missed

by $0.16

Q1'25

Missed

by $0.14

Q4'24

Missed

by $0.04

Q3'24

Est.

$-0.65

The last earnings report on August 14 showed earnings per share of -103 cents, missing the estimate of -87 cents. With 576.77K shares outstanding, the current market capitalization sits at 2.27B.

View a ticker or compare two or three

Compare

CELC

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if bought

View Trends For CELC
(Try 14 days for Free)

Interact to see
Advertisement

A.I.Advisor

published price charts

These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. CELC showed earnings on August 14, 2025. You can read more about the earnings report here.

View AI-Driven Trading

A.I. Advisor

published General Information

General Information

a biotechnology company develops novel diagnostic tests

Industry Biotechnology

Profile

Fundamentals

Details

Industry

Miscellaneous Commercial Services

Address

16305 36th Avenue North

Phone

+1 763 392-0767

Employees

Web

https://www.celcuity.com